Source:http://linkedlifedata.com/resource/pubmed/id/21048778
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-2-7
|
pubmed:abstractText |
It is controversial whether gestational hypertension (GH) and preeclampsia (PE) have the same pathophysiology. Our aim was to clarify whether the serum soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio and levels of soluble endoglin (sEng) are different in women with GH and with PE. In women with GH (15 cases), hypertension preceding PE (h-PE, 10 cases) and PE in which hypertension and proteinuria occurred simultaneously (si-PE, 36 cases), blood samples were collected after disease onset. The levels of log(10)(sFlt-1/PlGF) in women with GH were significantly lower than in women with h-PE and si-PE (1.65±0.39 vs. 2.22±0.35 and 2.15±0.46). The levels of log(10)sEng in women with GH were also significantly lower than in women with h-PE and si-PE (1.51±0.43 vs. 1.87±0.21 and 1.85±0.32). The incidence rates of the sFlt-1/PlGF ratio ?95th percentile of the reference value were 73, 100 and 92%, respectively, (P=0.080), and those of sEng ?95th percentile were 67, 100 and 89%, respectively, (P=0.053). In conclusion, the levels of sFlt-1/PlGF ratio and sEng in women with GH were lower than in those with h-PE and with si-PE; however, the majority of women with GH showed abnormal increases of both sFlt-1/PlGF ratio and sEng, suggesting that GH may be a subclinical PE in view of serum levels of angiogenesis-related factors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inducing Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/ENG protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/FLT1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Pregnancy Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/placenta growth factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1348-4214
|
pubmed:author |
pubmed-author:ArigaHarukoH,
pubmed-author:EguchiKazuoK,
pubmed-author:HirashimaChikakoC,
pubmed-author:MatsubaraShigekiS,
pubmed-author:OhkuchiAkihideA,
pubmed-author:OhmaruTakakoT,
pubmed-author:SuzukiHirotadaH,
pubmed-author:SuzukiMitsuakiM,
pubmed-author:TakahashiKayoK,
pubmed-author:YoshidaMikaM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
212-7
|
pubmed:meshHeading |
pubmed-meshheading:21048778-Adult,
pubmed-meshheading:21048778-Angiogenesis Inducing Agents,
pubmed-meshheading:21048778-Antigens, CD,
pubmed-meshheading:21048778-Female,
pubmed-meshheading:21048778-Humans,
pubmed-meshheading:21048778-Hypertension, Pregnancy-Induced,
pubmed-meshheading:21048778-Pre-Eclampsia,
pubmed-meshheading:21048778-Pregnancy,
pubmed-meshheading:21048778-Pregnancy Proteins,
pubmed-meshheading:21048778-Receptors, Cell Surface,
pubmed-meshheading:21048778-Vascular Endothelial Growth Factor Receptor-1
|
pubmed:year |
2011
|
pubmed:articleTitle |
Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|